510(k) device
Fluobeam LX
Fluoptics · Parathyroid Autofluorescence Imaging Device (QDG, Class II) · First FDA decision Jul 31, 2019, newest Jul 31, 2019Thyroid nodules and thyroid disease
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
5
Naming "Fluobeam LX"
MAUDE reports
1
Brand "Fluobeam LX", since 2015
PubMed studies
11
Mentioning "Fluobeam LX"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Fluobeam LX
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Fluobeam LX510(k)
K190891 · Decided Jul 31, 2019 · 117 days after receipt
Device type: Parathyroid Autofluorescence Imaging Device (QDG) · General & Plastic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Fluobeam LX", any status and sponsor, newest update first.
- WHITE CAP: Intra-operative Parathyroid Tissue Sensor (PTS)-Guided Assessment of Parathyroid Viability and Surgical Decision-MakingPivotal-lookingNot yet recruiting
Fujian Medical UniversityAcademic, hospital or other
NCT07043010 · 120 participants (planned) · Start Jul 1, 2025 · Primary completion Dec 31, 2029
Device: Near-Infrared Parathyroid Tissue Sensor Imaging (PTS) · For: Hyperparathyroidism, Primary; Parathyroid Neoplasms; Parathyroid Adenoma and 1 more
Sites: Fuzhou, China
- Intraoperative Identification of Parathyroid Adenomas Using PTeye™ and FLUOBEAM® LX: a Prospective Cohort StudyActive, not recruiting
Aristotle University Of ThessalonikiAcademic, hospital or other
NCT06788223 · 40 participants (planned) · Start Nov 1, 2024 · Primary completion Jan 31, 2025
Device: Parathyroidectomy · For: Primary Hyperparathyroidism Due to Adenoma
Sites: Thessaloniki, Greece
- Autofluorescence vs Clinical Assessment of Parathyroid Glands During Thyroid SurgeryPivotal-lookingCompleted
Region SkaneAcademic, hospital or other
NCT04509011 · 516 participants · Start Jan 5, 2021 · Primary completion Oct 1, 2022
Device: Fluobeam® LX · For: Hypoparathyroidism Postprocedural
Sites: Vienna, Austria; Bergen, Norway; Krakow, Poland · 5 sites in all
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Fluobeam LX", and for the whole product code for context.
This brand
1 reports: 1 malfunction, 0 injury, 0 death
Whole product code QDG
2 reports: 1 malfunction, 0 injury, 0 death
Newest reports for this brand
- FLUOBEAM LXMalfunction
3011092264-2026-00001 · Received Jun 19, 2026 · Event dated Apr 6, 2026
Device type: Parathyroid Autofluorescence Imaging Device (QDG)
Device problem as coded: Overheating of Device; Improper or Incorrect Procedure or Method
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Fluobeam LX"[tiab]. The summary above synthesizes these.
- Impact of autofluorescence for detection of parathyroid glands during thyroidectomy on postoperative parathyroid hormone levels: parallel multicentre randomized clinical trial.
Bergenfelz A, Barczynski M, Heie A, et al. · Br J Surg · 2023Randomized Controlled Trial, Multicenter Study
- Assessment of PTeyeࡊ versus FLUOBEAM® LX for parathyroid adenomas: a pilot case-control study.
Papavramidis T, Chorti A, Bakkar S · Updates Surg · 2025Comparative Study, Randomized Controlled Trial
- Feasibility of parathyroid gland autofluorescence imaging after indocyanine green fluorescence angiography.
Richard M, Rizo P · Front Endocrinol (Lausanne) · 2023Research Support, Non-U.S. Gov't
- Parathyroid gland identification and angiography classification using simple machine learning methods.
McEntee PD, Greevy JE, Triponez F, et al. · BJS Open · 2024
- Improvement in Central Neck Dissection Quality in Thyroid Cancer by Use of Tissue Autofluorescence.
Neagoe OC, Ionicg M · Cancers (Basel) · 2024
- Intraoperative detection of parathyroid glands by autofluorescence identification using image-based system: report of 15 cases.
Gorobeiko M, Dinets A · J Med Case Rep · 2021Case Reports
- Use of Indocyanine Green Fluorescence During Total Thyroidectomy to Identify Parathyroid Glands and Prevent Hypoparathyroidism.
Zhang D, Sun H, Frattini F, et al. · Surg Technol Int · 2022
- Comparison of the effectiveness of autofluorescence devices in the detection of parathyroid glands during thyroid operations: a propensity score matched analysis (PSM).
Voloudakis N, Lazaridou E, Atmatzidis S, et al. · Front Endocrinol (Lausanne) · 2026Comparative Study
- Near-Infrared Autofluorescence-Guided Parathyroid Identification During Pediatric Thyroidectomy for Thyroid Cancer: A Comparative Study.
Murawski M, Garnier H, Wojciechowska E, et al. · Head Neck · 2026
- Does parathyroid autofluorescence reduces unintentional parathyroidectomy during total thyroidectomy with central lymph node compartment dissection?
Chorti A, Pliakos I, Moysidis M, et al. · Updates Surg · 2026Randomized Controlled Trial
- Autofluorescence enhances intraoperative detection of parathyroid glands: a single-center comparative study.
Dubuis JB, Meyer J, Mavromati M, et al. · Front Endocrinol (Lausanne) · 2026Comparative Study
Other devices of this type
Also filed under product code QDG.
- FLUOBEAM LX Imaging System (FBLX)Fluoptics Sas (A Getinge Group Company} · 510(k) 2025
- Dendrite Imaging SystemDendrite Imaging, Inc. · 510(k) 2025
- FLUOBEAM® LX RedFluoptics Sas · 510(k) 2023
- Fluobeam 800 Clinic Imaging Device used with Fluocase 800 Control SystemFluoptics · De Novo 2018
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.